135 related articles for article (PubMed ID: 9376750)
21. [The assessment of the clinical efficacy, vasoactive and metabolic effects of mexidol in elderly patients with discirculatory encephalopathy].
Abramenko IuV
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 1):35-41. PubMed ID: 22611676
[TBL] [Abstract][Full Text] [Related]
22. [The effect of nimodipine and verapamil on the blood supply and vascular reactivity of the brain].
Beketov AI; Polevik IV
Farmakol Toksikol; 1991; 54(2):19-21. PubMed ID: 1909246
[TBL] [Abstract][Full Text] [Related]
23. [THE INFLUENCE OF SHORT-TIME CEREBRAL ISCHEMIA ON PIAL VESSELS ADRENOREACTIVITY IN RATS].
Gorshkova OP; Shuvaeva VN; Lensman MV; Artem'eva AI
Ross Fiziol Zh Im I M Sechenova; 2016 Jun; 102(6):659-67. PubMed ID: 30192491
[TBL] [Abstract][Full Text] [Related]
24. [ANTIARRHYTHMIC EFFECTS OF 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE HEMISUCCINATE IN COMPARISON TO MEXIDOL.].
Turilova AI; Gan'shina TS; Avdyunina NI; Pyatin BM; Mirzoyan RS
Eksp Klin Farmakol; 2016; 79(7):8-11. PubMed ID: 29782738
[TBL] [Abstract][Full Text] [Related]
25. Pre- and postischemic effects of the NMDA receptor antagonist dizocilpine maleate (MK-801) on collateral cerebral blood flow.
Robertson SC; Wetjen NM; Beer BJ; Loftus CM
J Neurosurg; 1997 Dec; 87(6):927-33. PubMed ID: 9384406
[TBL] [Abstract][Full Text] [Related]
26. Central role of TRPM4 channels in cerebral blood flow regulation.
Reading SA; Brayden JE
Stroke; 2007 Aug; 38(8):2322-8. PubMed ID: 17585083
[TBL] [Abstract][Full Text] [Related]
27. [Possibilities of antioxidant therapy for asthenia and cognitive deficit in elderly patients with chronic brain ischemia].
Duma SN
Ter Arkh; 2013; 85(12):100-5. PubMed ID: 24640678
[TBL] [Abstract][Full Text] [Related]
28. [Effect of euphylline and no-shpa on cerebrovascular resistance and the survivability of animals after cerebral ischemia].
Gaevyĭ MD; Ali AV
Farmakol Toksikol; 1987; 50(2):89-91. PubMed ID: 3582642
[TBL] [Abstract][Full Text] [Related]
29. [Cardioprotective effect of drugs with antioxidant activity in acute cerebral ischemia].
Stoliarova VV
Eksp Klin Farmakol; 2001; 64(6):31-3. PubMed ID: 11871234
[TBL] [Abstract][Full Text] [Related]
30. [The nonuniform sensitivity of the cerebral vessels to serotonin].
Mirzoian RS; Romanycheva NA; Gan'shina TS; Aleksandrin VV; Volobueva TI; Aleksandrov PN
Eksp Klin Farmakol; 1993; 56(3):22-5. PubMed ID: 8219983
[TBL] [Abstract][Full Text] [Related]
31. Pre-treatment with candesartan protects from cerebral ischaemia.
Ito T; Nishimura Y; Saavedra J
J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):174-9. PubMed ID: 11881119
[TBL] [Abstract][Full Text] [Related]
32. Anatomic considerations in therapeutic arteriogenesis for cerebral ischemia.
Liebeskind DS
Circulation; 2004 Jan; 109(2):e4; author reply e4. PubMed ID: 14734507
[No Abstract] [Full Text] [Related]
33. [Effect of 3-hydroxypyridine derivatives on the central nervous system].
Val'dman AV; Voronina TA; Smirnov LD; Tilekeeva UM; Diumaev KM
Biull Eksp Biol Med; 1985 Jan; 99(1):60-2. PubMed ID: 4038464
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the Possibility of Correction of Doxorubicin-Induced Chronic Heart Failure in the Experiment with 3-Hydroxypyridine Acetylcysteinate and 3-Hydroxypyridine Succinate.
Zamotaeva MN; Inchina VI; Konorev VV; Kuznetsov YV; Kuz'michev ND
Bull Exp Biol Med; 2018 Jul; 165(3):344-346. PubMed ID: 30006879
[TBL] [Abstract][Full Text] [Related]
35. [Intensification of neurogenic spasms of the cerebral vessels by naloxone].
Mirzoian RS; Gan'shina TS; Ragimov KhS
Farmakol Toksikol; 1988; 51(6):41-4. PubMed ID: 2853082
[TBL] [Abstract][Full Text] [Related]
36. [Effect of blocking angiotensin receptors on cerebral blood flow in the post-ischemic period in hypertensive rats].
Adzhienko LM
Patol Fiziol Eksp Ter; 2001; (4):23-5. PubMed ID: 11871024
[TBL] [Abstract][Full Text] [Related]
37. [Effect of calcium antagonist nimodipine and induced hypertension on cerebral vessel reactivities, cerebral blood flow, cerebral edema and infarction in cats with one hour middle-cerebral-artery occlusion].
Sakaki T; Ishida T; Sasaoka Y; Thunoda S; Utsumi S
No Shinkei Geka; 1990 May; 18(5):423-30. PubMed ID: 2385317
[TBL] [Abstract][Full Text] [Related]
38. [Efficiency of etoxidol in treating cardiovascular disorders caused by experimental cerebral ischemia].
Blinov DS; Sernov LN; Blinova EV; Balashov VP; Gogina ED; Van'kova LV; Skachilova SIa; Lebedev AB; Belova LA
Eksp Klin Farmakol; 2011; 74(7):13-5. PubMed ID: 21894761
[TBL] [Abstract][Full Text] [Related]
39. [Experimental and clinical research on the effect of senzit on the cerebral blood flow and hemostatic function in cerebral ischemia].
Burtsev EM; Miller LG; Gushchin AS; Shprakh VV; Savkov VS
Farmakol Toksikol; 1986; 49(5):97-101. PubMed ID: 3770185
[TBL] [Abstract][Full Text] [Related]
40. [Does the capacity for autoregulation of cerebrovascular circulation depend on gestational age?].
Jorch G; Jorch N
Monatsschr Kinderheilkd; 1987 Nov; 135(11):744-7. PubMed ID: 3431555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
